Medical Care Technologies Inc. Introduces AI Breakthrough for Squamous Cell Carcinoma Detection

September 22, 2025 9:00 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced a significant innovation in dermatological AI: a platform capable of detecting squamous cell carcinoma (SCC), the second most common skin cancer and a condition responsible for more than 15,000 deaths annually in the United States alone.Early SCC detection is critical, as the cancer can spread to lymph nodes and distant organs if untreated. MDCE's AI platform uses advanced machine...

Read more

The Midwife & More Celebrates Historic Milestone as First Certified Nurse Midwife Granted Hospital Privileges at Los Robles Hospital

September 22, 2025 9:00 AM

After months of anticipation, The Midwife & More proudly announces a groundbreaking achievement: Christy Cannon, CNM/WHNP-BC, has officially become the first-ever Certified Nurse Midwife with privileges at Los Robles Hospital. This milestone marks the introduction of hospital-based midwifery care for families in Conejo Valley."We've been waiting months for this moment, and it's finally here," said Cannon. "It is an honor to bring midwifery into...

Read more

MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog

September 22, 2025 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel oral therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced topline results from the single ascending dose (SAD) portion of its ongoing Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of its lead oral candidate, Ketamir-2, in healthy volunteers.The...

Read more

Red drop LAB. - a Swiss Startup Transforms Menstrual Blood Into an Innovative Diagnostic Tool

September 20, 2025 9:00 PM

What if every menstrual cycle became an opportunity to better understand women's health? This is the bold vision of Red drop LAB., a young Swiss company developing a groundbreaking solution to analyze menstrual blood as a source of biological indicators.A Medical Innovation Born in SwitzerlandWhile biomedical research has long overlooked menstruation, Red drop LAB. aims to close this gap by unlocking the potential of this natural, abundant, and...

Read more

BioNxt Solutions Announces Closing of Shares for Debt Settlement

September 19, 2025 9:45 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT) is pleased to announce that, further to its news release of September 12, 2025, it has closed its debt settlement with an arm's length creditor (the "Creditor") related to an aggregate of $225,010 in debt (the "Debt") owing for services provided by the Creditor to the Company. In full satisfaction and settlement of the Debt, the Company issued an aggregate of...

Read more

Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals

September 19, 2025 7:30 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that Terry Lynch, CEO of Power Metallic Mines Inc. (TSX-V: PNPN), will continue his role as a capital markets advisor to the Company. Mr. Lynch brings decades of early-stage capital markets experience in the resource and bioscience sectors as well an extensive and influential international investment network.The Company is also pleased to...

Read more

Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies

September 19, 2025 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO )(OTCQB:ONNVF )(Frankfurt:W1H) (WKN: A3EKSZ ) (" Onco " or the " Company ") is pleased to announce that Dalton Pharma Services ("Dalton") has commenced activities to manufacture Onco's proprietary nanoparticle formulation, also know as PEO-b-PBz-CL 1 , a key component of the Company's novel drug delivery platform which is designed for use in conjunction with Onco's proprietary Polynucleotide Kinase...

Read more

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories

September 19, 2025 3:10 PM

Moderna announced today that the first mRNA vaccines fully manufactured in Canada are being shipped to provinces and territories. This milestone advances Canada's domestic vaccine production capacity and strengthens national health security."The delivery of the first made-in-Canada mRNA vaccines to provinces and territories across the country marks a major milestone in our partnership with Canada," said Stéphane Bancel, Chief Executive Officer...

Read more

Medical Components Specialists to Exhibit at Medical Technology Ireland 2025

September 19, 2025 10:00 AM

Medical Components Specialists (MCS), a leading contract manufacturer of precision medical devices, announced its participation in the upcoming Medical Technology Ireland Expo and Conference, taking place September 24-25 at the Galway Racecourse. Medical Technology Ireland has become Europe's second-largest and fastest-growing medical device design event. This year, the conference is expected to draw more than 2,000 attendees and over 350...

Read more

Medical Care Technologies Inc. Launches AI Platform for Early Basal Cell Carcinoma Detection

September 19, 2025 9:00 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), a pioneer in AI-powered diagnostics, today unveiled its breakthrough artificial intelligence platform for the detection and monitoring of basal cell carcinoma (BCC), the most common form of skin cancer.Though rarely fatal, untreated BCC can cause severe disfigurement, local tissue invasion, and costly surgeries. Current detection methods rely heavily on dermatology access, which remains limited for...

Read more

MaxWell Clinic Enters Eighth Year of Offering Habitat Optimizing Plasma Exchange a Promising Therapy for Alzheimers Disease

September 19, 2025 8:30 AM

In recognition of World Alzheimer's Day on September 21, MaxWell Clinic today announced that it is entering its eighth year of offering a promising therapy for patients and families affected by Alzheimer's disease. The clinic is home to the nation's largest private outpatient apheresis center and the only patented program offering Habitat Optimizing Plasma Exchange® (H.O.P.E.), an advanced form of therapeutic plasma exchange designed to support...

Read more

Genflow Biosciences PLC Announces Holding(s) in Company

September 19, 2025 8:15 AM

TR-1: Standard form for notification of major holdings1. Issuer DetailsISINGB00BP2C3V08Issuer NameGENFLOW BIOSCIENCES PLCUK or Non-UK IssuerUK2. Reason for NotificationAn acquisition or disposal of voting rights3. Details of person subject to the notification obligationNameJonathan Mark SwannCity of registered office (if applicable)rickmansworthCountry of registered office (if applicable)United Kingdom4. Details of the shareholderFull name of...

Read more

Genflow Strengthens IP Portfolio

September 19, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, today announces that it has filed a formal request for the examination of its patent application entitled SIRT6 Variants for NASH in China.The application covers proprietary variants of the SIRT6 gene designed to address Non-Alcoholic Steatohepatitis (NASH), a severe progressive liver disease with limited treatment...

Read more

IBYC Selects Makeer Intelligence as Exclusive Hardware Partner and Launches Canada-Focused Pilot for Multilingual Asian Seniors

September 18, 2025 12:30 PM

IBYC AI Healthcare Inc. ("IBYC") today announced an exclusive strategic partnership with Makeer Intelligence (Shenzhen) Co., Ltd. ("Makeer") to co-create a new generation of AI-powered health wearables that are designed in Canada and assembled in China. In parallel, IBYC is launching a Canada-focused home health-monitoring pilot for multilingual seniors (55+) and family caregivers, as Canada approaches "super-aged" status with nearly one-quarter...

Read more

Kevin R. Hanz, MD Aesthetic Plastic Surgery Recognized Across Three Categories in DFW Favorites

September 18, 2025 11:00 AM

Kevin R. Hanz, MD Aesthetic Plastic Surgery Recognized as a DFW Favorites Cosmetic Surgery Practice and Honored for Best Liposuction and Breast Augmentation in DallasDallas, TX - September 18, 2025- Kevin R. Hanz, MD, Aesthetic Plastic Surgery is proud to announce that the practice has been named a DFW Favorites Cosmetic Surgery Practice, with Dr. Kevin Hanz also recognized among the best in Dallas for Liposuction and Breast Augmentation.The DFW...

Read more

Dr. Scott Kamelle Reaches 3,000 Da Vinci Robotic Surgery Cases, Cementing His Role as a Leader in Minimally Invasive Cancer Care

September 18, 2025 10:00 AM

Dr. Scott Kamelle, a highly respected figure in gynecologic oncology, has reached an extraordinary milestone in his surgical career: completing 3,000 procedures using the Da Vinci robotic surgical system. This achievement distinguishes Dr. Kamelle as one of the most experienced robotic surgeons in the country and underscores his lifelong dedication to advancing patient care through innovation and precision. The Da Vinci surgical system,...

Read more

DirectTrust(R) Releases New 2026 Accreditation Criteria Versions for Public Review through November 17, 2025

September 18, 2025 9:00 AM

DirectTrust®, a non-profit healthcare industry alliance focused on furthering trust in healthcare data exchange through standards, accreditation, and other services, today announced it has posted new versions of program criteria for its 28 accreditation programs for public review and comment. The open process for adopting criteria commenced on September 18 and closes on November 17, 2025.A key update for 2026 is the launch of the new Artificial...

Read more

Medical Care Technologies Inc. Unveils Breakthrough AI for Early Melanoma Detection

September 18, 2025 8:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE), a leader in AI-powered preventive healthcare, today announced a major advancement in dermatology: an artificial intelligence platform designed to revolutionize the early detection of melanoma, the deadliest form of skin cancer.Melanoma accounts for only 1% of skin cancers but causes the majority of skin cancer deaths worldwide. Early intervention is critical-when caught in its initial stages,...

Read more

ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy

September 18, 2025 8:15 AM

ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (NASDAQ:KRMD) today jointly announced an agreement leveraging KORU Medical's FreedomEDGE® infusion system as part of ForCast's technology platform for the treatment of periprosthetic joint infection (PJI). PJI is a rare but serious complication of joint replacement procedures, and is challenging to treat because the infecting bacteria adhere to the prothesis and can form a protective...

Read more

Nolla Health Debuts AI-Powered Skin Health Platform In U.S. So You Can Ditch Your Dermatologist's Waitlist

September 18, 2025 8:00 AM

Nolla Health, the company pioneering AI-powered personal healthcare, today announced its U.S. launch across 40+ states, introducing a "Personal Care Companion for Your Skin" that makes dermatologist-level treatment more accessible than ever. The launch and opening of its U.S. headquarters in New York City comes on the heels of a $4.5 million seed round led by General Catalyst, with participation from SNÖ Ventures and Commure founder Diede van...

Read more